Biogen | BIIB - Capitalización De Mercado

Precio De Mercado
195.18
Cambio Diario
11.80 6.43%
Mensual
4.06%
Anual
61.20%
Q2 Expectativa
180.43




Capitalización De Mercado Cambio Fecha
AbbVie USD 355.2B 48.64B 2026-04
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 176.25B 24.32B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 27.49B 589M 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Incyte USD 21.96B 3.23B 2026-04
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 231.75B 76B 2026-04
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Sanofi EUR 101.43B 1.16B 2026-04
Sanofi EUR 117.34B 2.45B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 107.27B 72.99B 2026-04
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12